---
name: scientific-writing
description: Comprehensive scientific and medical manuscript writing skill. Features IMRAD structure, 5 workflow modes (plan-outline, write, review, switch-venue, switch-language), humanization to remove AI patterns, diagram integration, citation management, and reporting guidelines (CONSORT/STROBE/PRISMA). For research papers, journal submissions, and academic writing.
---

# Scientific Writing

A comprehensive skill for writing scientific manuscripts with precision, clarity, and human-like prose. Integrates academic workflows, medical writing standards, AI pattern removal, and diagram creation.

## Overview

This skill combines:
- **Academic workflows** (plan-outline, write, review, switch-venue, switch-language)
- **Medical AI writing standards** (clinical validation, ethics compliance)
- **Humanization** (remove 24 AI writing patterns)
- **Diagram integration** (draw.io for scientific figures)
- **IMRAD structure** (Introduction, Methods, Results, And Discussion)
- **Citation management** (APA, AMA, Vancouver, Chicago, IEEE)
- **Reporting guidelines** (CONSORT, STROBE, PRISMA, STARD, TRIPOD)

**Critical Principle: Always write in full paragraphs with flowing prose. Never submit bullet points in the final manuscript.**

---

## Core Workflow Modes

### 1. `plan-outline` (Ê¶ÇË¶ÅËßÑÂàí)

**Purpose**: Generate paper outline and content structure.

**Process**:
1. Identify one-sentence core contribution
2. Build IMRAD structure around central narrative
3. Plan figures and tables as the backbone
4. Determine target journal and reporting guidelines

**Output**: Structured outline with:
- Section breakdown
- Key points per section
- Planned figures/tables
- Citation placeholders

### 2. `write` (Á´†ËäÇÂÜô‰Ωú‰∏éÊï¥Âêà)

**Purpose**: Draft sections with active delivery and consistency.

**Features**:
- **Two-stage process**: 
  - Stage 1: Create bullet-point outline
  - Stage 2: Convert to full flowing prose
- **Auto-adapt**: Adjust content depth for venue (e.g., NeurIPS 9 pages, ICML 8 pages)
- **Citation integration**: Natural incorporation of references
- **Field-specific terminology**: Match discipline conventions

**After Writing - Mandatory Humanization**:
```
After completing any draft, ALWAYS run humanization to remove AI patterns:
- Remove inflated significance language
- Fix superficial -ing phrases
- Replace vague attributions with specific sources
- Eliminate promotional/advertising tone
- Remove filler transitions
- Vary sentence structure naturally
```

### 3. `review` (Â§öÂÆ°Á®ø‰∫∫ËØÑÂÆ°)

**Purpose**: Simulate multi-reviewer critique.

**Process**:
- Simulate 2-3 reviewers with different perspectives
- Check: Originality, methodology, statistics, clarity, ethics
- Generate structured review with actionable feedback
- Output: `review.md` with revision suggestions

### 4. `switch-venue` (Ê∏†ÈÅìÂàáÊç¢)

**Purpose**: Adapt manuscript for different journals/conferences.

**Adjustments**:
- Page limits and section structure
- Citation format (APA ‚Üí AMA ‚Üí Vancouver)
- Abstract style (structured vs. unstructured)
- Ethical statements requirements
- Figure/table specifications
- Broader Impact or Limitations sections

### 5. `switch-language` (ËØ≠Ë®ÄÂàáÊç¢)

**Purpose**: Toggle between English and Chinese writing.

**English Mode**:
- Concise, direct prose
- Avoid over-decoration
- Active voice preferred
- Simple constructions (is/are/has)

**Chinese Mode** (‰∏≠ÊñáÊ®°Âºè):
- Follow Chinese copywriting guidelines
- Proper spacing between Chinese and English
- Full-width punctuation
- Natural Chinese academic tone

---

## Writing Process: Two-Stage Method

### Stage 1: Create Section Outlines with Key Points

Create structured outline with bullet points:
- Main arguments or findings
- Key studies to cite
- Data points and statistics
- Logical flow markers

**Example outline (Introduction):**
```
- Background: AI in drug discovery gaining traction
  * Cite recent reviews (Smith 2023, Jones 2024)
  * Traditional methods slow and expensive
- Gap: Limited application to rare diseases
  * Only 2 prior studies (Lee 2022, Chen 2023)
- Our approach: Transfer learning
- Study objectives: Validate on 3 datasets
```

### Stage 2: Convert to Full Paragraphs

Transform bullets into flowing prose:
1. **Complete sentences** with subjects, verbs, objects
2. **Add transitions** (however, moreover, subsequently)
3. **Integrate citations** naturally within sentences
4. **Expand context** that bullets omit
5. **Ensure logical flow** within paragraphs
6. **Vary sentence structure** for engagement

**Example prose:**
```
Artificial intelligence approaches have gained significant traction in drug 
discovery pipelines over the past decade (Smith, 2023; Jones, 2024). While 
these computational methods show promise for accelerating therapeutic 
candidate identification, traditional experimental approaches remain slow 
and resource-intensive. However, AI application to rare diseases has been 
limited, with only two prior studies demonstrating proof-of-concept results 
(Lee, 2022; Chen, 2023). The primary obstacle has been the scarcity of 
training data for conditions affecting small patient populations.
```

---

## Humanization: Remove AI Writing Patterns

### 24 Patterns to Detect and Fix

#### Content Patterns

**1. Significance Inflation**
- ‚ùå "marking a pivotal moment in the evolution of..."
- ‚úÖ "was established in 1989 to collect regional statistics"

**2. Notability Name-Dropping**
- ‚ùå "cited in NYT, BBC, FT, and The Hindu"
- ‚úÖ "In a 2024 NYT interview, she argued..."

**3. Superficial -ing Phrases**
- ‚ùå "symbolizing... reflecting... showcasing..."
- ‚úÖ Remove or expand with actual sources

**4. Promotional Language**
- ‚ùå "nestled within the breathtaking region"
- ‚úÖ "is a town in the Gonder region"

**5. Vague Attributions**
- ‚ùå "Experts believe it plays a crucial role"
- ‚úÖ "according to a 2019 survey by..."

**6. Formulaic Challenges Sections**
- ‚ùå "Despite challenges... continues to thrive"
- ‚úÖ Specific facts about actual challenges

#### Language Patterns

**7. AI Vocabulary Overuse**
- ‚ùå "Additionally... testament... landscape... showcasing"
- ‚úÖ "also... remain common"

**8. Copula Avoidance**
- ‚ùå "serves as... features... boasts"
- ‚úÖ "is... has"

**9. Negative Parallelisms**
- ‚ùå "It's not just X, it's Y"
- ‚úÖ State directly

**10. Rule of Three**
- ‚ùå "innovation, inspiration, and insights"
- ‚úÖ Natural number of items

**11. Synonym Cycling**
- ‚ùå "protagonist... main character... central figure... hero"
- ‚úÖ "protagonist" (repeat when clearest)

**12. False Ranges**
- ‚ùå "from X to Y, from A to B"
- ‚úÖ List topics directly

#### Style Patterns

**13. Em Dash Overuse**
- ‚ùå "institutions‚Äînot the people‚Äîyet this continues‚Äî"
- ‚úÖ Use commas or periods

**14. Boldface Overuse**
- ‚ùå "**OKRs**, **KPIs**, **BMC**"
- ‚úÖ "OKRs, KPIs, BMC"

**15. Inline-Header Lists**
- ‚ùå "**Performance:** Performance improved"
- ‚úÖ Convert to prose

**16. Title Case in Headings**
- ‚ùå "Strategic Negotiations And Partnerships"
- ‚úÖ "Strategic negotiations and partnerships"

**17. Emojis**
- ‚ùå "üöÄ Launch Phase: üí° Key Insight:"
- ‚úÖ Remove emojis

**18. Curly Quotes**
- ‚ùå `said "the project"`
- ‚úÖ `said "the project"`

#### Communication Patterns

**19. Chatbot Artifacts**
- ‚ùå "I hope this helps! Let me know if..."
- ‚úÖ Remove entirely

**20. Knowledge-Cutoff Disclaimers**
- ‚ùå "While details are limited in available sources..."
- ‚úÖ Find sources or remove

**21. Sycophantic Tone**
- ‚ùå "Great question! You're absolutely right!"
- ‚úÖ Respond directly

#### Filler and Hedging

**22. Filler Phrases**
- ‚ùå "In order to", "Due to the fact that"
- ‚úÖ "To", "Because"

**23. Excessive Hedging**
- ‚ùå "could potentially possibly"
- ‚úÖ "may"

**24. Generic Positive Conclusions**
- ‚ùå "The future looks bright"
- ‚úÖ Specific plans or facts

---

## IMRAD Structure

### Introduction
- Establish research problem importance
- Review relevant literature systematically
- Identify knowledge gaps
- State clear research questions/hypotheses
- Explain study novelty and significance

### Methods
- Detailed participant/sample descriptions
- Clear procedural documentation
- Statistical methods with justification
- Equipment and materials specifications
- Ethical approval and consent statements

### Results
- Logical flow from primary to secondary outcomes
- Integration with figures and tables
- Statistical significance with effect sizes
- Objective reporting without interpretation

### Discussion
- Relate results to research questions
- Compare with existing literature
- Acknowledge limitations honestly
- Propose mechanistic explanations
- Suggest practical implications and future research

---

## Citation Styles

**AMA (American Medical Association)**
- Numbered superscript citations
- Common in medicine

**Vancouver**
- Numbered citations in square brackets
- Biomedical standard

**APA (American Psychological Association)**
- Author-date in-text citations
- Common in social sciences

**Chicago**
- Notes-bibliography or author-date
- Humanities and sciences

**IEEE**
- Numbered square brackets
- Engineering and computer science

---

## Reporting Guidelines

**CONSORT**: Randomized controlled trials
**STROBE**: Observational studies
**PRISMA**: Systematic reviews and meta-analyses
**STARD**: Diagnostic accuracy studies
**TRIPOD**: Prediction model studies
**ARRIVE**: Animal research
**CARE**: Case reports
**SQUIRE**: Quality improvement studies
**SPIRIT**: Study protocols
**CHEERS**: Economic evaluations

---

## Diagram Integration

### Creating Scientific Figures

Use drawio-skills to create publication-ready diagrams:

```bash
# Create workflow diagram
/drawio create a CONSORT flowchart for clinical trial participant flow

# Create architecture diagram
/drawio create system architecture for ML pipeline with data flow

# Replicate from existing figure
/drawio replicate [upload image of existing figure]
```

### Figure Requirements
- **Minimum**: 3-4 figures per paper
- **Graphical Abstract**: Visual summary of entire paper
- **Study Design**: CONSORT/STROBE/PRISMA flowcharts
- **Results**: Data visualization (bar charts, line graphs, box plots)
- **Conceptual**: Mechanism diagrams, workflow illustrations

### Figure Types
- Bar graphs: Comparing discrete categories
- Line graphs: Trends over time
- Scatterplots: Correlations
- Box plots: Distributions and outliers
- Heatmaps: Matrices and patterns
- Flowcharts: Study design, participant flow

---

## Medical AI Writing Standards

### Clinical Validation Check
- Dataset partitioning (external validation included?)
- Statistical methods appropriate (p-value, CI)
- Metrics: Sensitivity, Specificity, AUC, F1
- Reference standard clearly defined

### Ethics Compliance Check
- IRB approval mentioned
- Patient informed consent documented
- Data anonymization procedures
- Potential biases acknowledged

### Med-AI Narrative Structure
1. **Clinical Context**: Current standard of care
2. **Gap**: Unmet clinical need or limitation
3. **Innovation**: How AI addresses the gap
4. **Clinical Impact**: Potential benefit to patients

---

## Field-Specific Terminology

### Biomedical Sciences
- Precise anatomical terminology
- ICD/DSM/SNOMED-CT nomenclature
- Generic drug names first
- "Patients" (clinical), "participants" (community)
- HGVS nomenclature for genetic variants

### Molecular Biology
- Italics for gene symbols: *TP53*
- Regular font for proteins: p53
- Full organism names at first mention
- Standard genetic notation: +/+, +/-, -/-

### Chemistry
- IUPAC nomenclature
- Concentrations: mM, ŒºM, nM

---

## Best Practices Summary

1. **Always write in full paragraphs** - Never submit bullet points
2. **Use two-stage process** - Outline first, then prose
3. **Humanize after writing** - Remove all 24 AI patterns
4. **Follow IMRAD** - Standard scientific structure
5. **Apply reporting guidelines** - CONSORT/STROBE/PRISMA
6. **Use proper citations** - Match journal requirements
7. **Create effective figures** - Self-explanatory with captions
8. **Maintain field terminology** - Match your discipline
9. **Be concise and clear** - Short sentences, precise language
10. **Check consistency** - Terminology, abbreviations, notation

---

## Common Pitfalls to Avoid

**Top Rejection Reasons:**
1. Inappropriate or insufficient statistics
2. Over-interpretation of results
3. Poorly described methods
4. Small or biased samples
5. Poor writing quality
6. Inadequate literature review
7. Unclear figures/tables
8. Failure to follow reporting guidelines

**Writing Quality Issues:**
- Mixing tenses inappropriately
- Excessive jargon or undefined acronyms
- Missing transitions between sections
- Inconsistent notation

---

## Workflow for Manuscript Development

**Stage 1: Planning**
1. Identify target journal and review guidelines
2. Determine reporting guideline
3. Outline IMRAD structure
4. Plan figures and tables

**Stage 2: Drafting** (Two-stage for each section)
1. Write Methods (easiest first)
2. Draft Results (describe figures objectively)
3. Compose Discussion (interpret findings)
4. Write Introduction (set up research question)
5. Craft Abstract (synthesize complete story)
6. Create Title (concise and descriptive)

**Stage 3: Humanization**
1. Check all 24 AI patterns
2. Remove inflated language
3. Add specific sources
4. Vary sentence structure
5. Ensure natural flow

**Stage 4: Revision**
1. Check logical flow throughout
2. Verify consistency
3. Ensure figures self-explanatory
4. Confirm reporting guidelines
5. Verify citations accurate
6. Proofread for clarity

**Stage 5: Final Preparation**
1. Format per journal requirements
2. Prepare supplementary materials
3. Write cover letter
4. Complete submission checklists
5. Gather required statements

---

## Integration with Other Skills

This skill works with:
- **content-research-writer**: General writing and research
- **humanizer**: Remove AI patterns (24 patterns)
- **drawio-skills**: Create scientific diagrams
- **NotebookLM**: Query research sources
- **docx-processing**: Create Word documents

---

## Examples

### Example 1: Introduction (Outline ‚Üí Prose)

**Outline:**
```
- Background: CML treatment with TKIs
  * Imatinib revolutionized treatment (Druker et al., 2001)
  * 2nd-gen TKIs improved responses but toxic
- Gap: Need better first-line options
  * T315I mutation resistant
- New approach: Asciminib (STAMP inhibitor)
- Study objectives: Compare asciminib vs standard TKIs
```

**Prose:**
```
The introduction of tyrosine kinase inhibitors (TKIs) revolutionized the 
treatment of chronic myeloid leukemia (CML), with imatinib first demonstrating 
the potential for targeted therapy in this disease (Druker et al., 2001). 
Subsequent second-generation TKIs improved molecular response rates but introduced 
new challenges, including cardiovascular toxicity and intolerance in a subset 
of patients. Despite these advances, significant unmet needs remain, particularly 
for patients with the T315I gatekeeper mutation who are resistant to most 
available TKIs.

Asciminib represents a novel therapeutic approach as a first-in-class STAMP 
(Specifically Targeting the ABL Myristoyl Pocket) inhibitor. Unlike ATP-competitive 
TKIs, asciminib binds allosterically to the myristoyl pocket of the BCR-ABL1 
protein, a mechanism that not only circumvents resistance mutations in the 
ATP-binding site but also demonstrates activity against the T315I mutation. 
This distinct mechanism, combined with a favorable safety profile, positions 
asciminib as a promising candidate for first-line CML therapy.
```

### Example 2: Results (Bad vs. Good)

**Poor (AI-sounding with bullet points):**
```
The results were significant. Key findings include:
- MMR rate: 67.7% vs 49.0%
- p-value: <0.001
- Follow-up: 48 weeks
```

**Good (humanized prose):**
```
At 48 weeks, the major molecular response (MMR) rate was significantly higher 
in the asciminib group compared to the standard TKI group (67.7% vs. 49.0%; 
p < 0.001). This difference was consistent across predefined subgroups, 
including age, Sokal risk score, and baseline disease burden.
```

---

## References

**Reporting Guidelines:**
- CONSORT: http://www.consort-statement.org/
- STROBE: https://www.strobe-statement.org/
- PRISMA: http://www.prisma-statement.org/

**Citation Styles:**
- AMA Manual of Style: https://www.amamanualofstyle.com/
- APA Publication Manual: https://apastyle.apa.org/
- Vancouver Style: https://www.nlm.nih.gov/bsd/uniform_requirements.html

**Writing Resources:**
- Wikipedia: Signs of AI writing
- Strunk & White: The Elements of Style
- Booth et al.: The Craft of Research

---

*Enhanced scientific writing skill integrating academic workflows, medical AI standards, humanization (24 AI patterns), and diagram creation.*
